4//SEC Filing
Townsend Richard Nolan 4
Accession 0001415889-25-013819
CIK 0001907108other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:00 PM ET
Size
4.9 KB
Accession
0001415889-25-013819
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-05-16$2.77/sh−1,074$2,979→ 221,173 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 133,827 RSUs.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:00 PM ET
- Size
- 4.9 KB